company info

company info

company info

Name Genome Pharmaceuticals Institute Co., Ltd.
Founded Dec. 21, 2000
Capital
36,373,095 yen
Our Business

Purpose
A bio-venture company of cooperation between industry and academia. And that is established to rely on research of Professor Sekimizu of University of Tokyo to put into practical use.

Area
1.To develop antibiotics
2.To develop functional health foods using innate stimulant index, and its entrusted business
3.To develop disease models using silkworm, and its entrusted business

Place *head office 1-27-8-1207 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
*lab. & office Office: 102 Next Building,  3-24-17 Hongo,
Bunkyo-ku, Tokyo 113-0033, Japan
Tel: +81 3 5684 8570
Lab: 201B The University of Tokyo Kashiwa Venture Plaza,
5-4-19, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan
Tel: +81 4 7128 8066

Corporate History

2000 December Founded as limited company
2001 April Started business with Japanese major pharmaceutical company based on collaborative research agreement
2005 March Capitalized by NIF ventures Co., Ltd.
May Opened Wet Lab. at sotokanda, chiyoda-ku, Tokyo
May Reorganized and incorporated. Company name changed to
Genome Pharmaceuticals Institute Co., Ltd.
2007 July Joined to the basic research by National Institute of Biomedical
Innovation as an implementation institute
(研究プロジェクト名:カイコ幼虫感染症モデルを用いた、バイオアッセ
イによる感染症治療薬シーズの開発)
August Moved to University of Tokyo Entrepreneur Plaza, Hongo, Bunkyo-ku, Tokyo
2008 July Our theme was selected for “Practical Application of the Results of Innovative Research by Universities and other Institutions” by Japan Science and Technology Agency (JST)
研究課題名:カイコをテスターとする、農産物、食品、並びに環境の毒性・病原性試験法の開発